Etomidate bulk supplier for pharma manufacturers

Etomidate 2 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Injection/Emulsion

Available Strengths: 2 mg/mL

Reference Brands: Amidate(US); Etomidate-Lipuro(EU)

Etomidate is a fast-acting IV anesthetic used for induction and emergency intubation, available in 2 mg/mL strength. Leading brands include Amidate, Etomidate-Lipuro, and Hameln. A key ICU and OR medication, Etomidate is widely sourced via pharma B2B platforms for hospitals, emergency departments, and critical care units.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Etomidate is a rapid-onset intravenous anesthetic agent used primarily for the induction of general anesthesia and rapid sequence intubation (RSI), particularly in hemodynamically unstable patients. It is available as a 2 mg/mL solution in 10 mL and 20 mL vials, ampoules, or pre-filled syringes. In the US, Etomidate is marketed under the brand name Amidate by Pfizer, along with generics from Baxter, Hikma, and others. In the EU, Etomidate-Lipuro by B. Braun and Hameln brands are widely distributed. Etomidate is a critical care medication supplied through pharma B2B platforms to hospitals, emergency units, and surgical centers worldwide.

Etomidate — third party manufacturing & bulk supply

Etomidate 2 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Etomidate is supplied as Intravenous (IV) Injection/Emulsion — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Etomidate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Etomidate →

Back to Listing

Frequently Asked Questions

Etomidate injection is used for the induction of general anesthesia and for short surgical or diagnostic procedures. It is commonly administered intravenously to induce rapid unconsciousness, especially in emergency settings where cardiovascular stability is important.

Etomidate injection is made from etomidate, a short-acting intravenous anesthetic agent. It works by enhancing the activity of gamma-aminobutyric acid (GABA) in the central nervous system, producing hypnosis with minimal effects on heart rate and blood pressure.

The most well-known trade name is Amidate.

Amidate was originally developed and marketed by Janssen Pharmaceuticals. Currently, etomidate injection is manufactured and distributed by various pharmaceutical companies worldwide depending on regional approvals.

The generic name is etomidate.

The brand name is Amidate.

Etomidate injection is manufactured in GMP-certified pharmaceutical facilities in the United States, Europe, India, and other regulated markets depending on the marketing authorization holder and supplier. Specific manufacturing locations vary by brand and batch.